
UB476
ProductAmiodarone Hydrochloride Injection
Strength150mg/3mL, 450mg/9mL, 900mg/18mL
IndicationsVentricular arrhythmia; Supraventricular arrhythmia; Atrial fibrillation; Ventricular tachycardia
TherapeuticsCardiovascular
GMPUS - FDA
RegistrationUnited States
ModalitiesSmall Molecule
Exclusive Summary
- - Long off-patent with broad generic availability and US registration, enabling multi-country fast access; - Anchored in AHA/ERC resuscitation guidelines and WHO EML, ensuring steady hospital emergency demand; - Three strengths (150/3mL, 450/9mL, 900/18mL) cover bolus and maintenance infusion, reducing compounding and waste; - US registration and compliance serve as regulatory reliance and quality credentials to win tenders and distribution; - Compared with originator and premix bags, conventional vials typically deliver 30–90% price savings to drive uptake.
我们能如何帮助您?
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →